کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6185842 1254386 2013 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studies
ترجمه فارسی عنوان
نقش پیش آگهی سیکلوکوسیژیناز 2 در سرطان تخمدان اپیتلیال: یک متاآنالیز مطالعات مشاهده شده
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
چکیده انگلیسی

ObjectiveThe aim of this study was to evaluate the prognostic significance of cyclooxygenase-2 (COX-2) on survival in patients with ovarian cancer by using a meta-analysis of observational studies.MethodsWe searched Pubmed and Embase to retrieve observational studies evaluating the association between COX-2 status and survival in patients with ovarian cancer. Hazards ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were pooled across studies using a random-effects model.ResultsA total of 17 studies were included in this meta-analysis to estimate the association between COX-2 and overall survival (OS), disease-free survival (DFS), response to chemotherapy (RC), and other clinical parameters. In a random-effects meta-analysis of 15 studies, higher COX-2 expression significantly predicted poor OS (death HR, 1.34; 95% CI, 1.05-1.71; I2 = 56.5%). A more prominent association was found between COX-2 expression and poor OS when studies with adjustment for age, stage, and histology were included (death HR, 1.65; 95% CI, 1.25-2.17; I2 = 0%). However, higher COX-2 expression was not significantly associated with poor DFS (recurrence HR, 1.36; 95% CI, 0.79-2.33; I2 = 53.6%) and RC (OR, 1.89; 95% CI, 0.85-4.21; I2 = 17.6%). There was a marginally significant association between COX-2 positivity and several clinical parameters such as age, stage, and histology. The pooled ORs of higher COX-2 expression were 1.75 (95% CI, 1.01-3.04) for advanced stages, 1.34 (95% CI, 0.97-1.85) for old age, and 1.42 (95% CI, 0.98-2.05) for serous cancer in histologic type, respectively.ConclusionsThe present meta-analysis suggests that higher COX-2 expression may be an independent risk factor for poor OS in patients with ovarian cancer.

► We performed a meta-analysis to evaluate the prognostic role of cyclooxygenase-2 (COX-2) in patients with ovarian cancer. ► This study showed that higher COX-2 expression was significantly associated with poor overall survival. ► Among studies which controls for covariates, a more prominent association was found between COX-2 expression and poor overall survival.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 129, Issue 3, June 2013, Pages 613-619
نویسندگان
, , ,